| Literature DB >> 6624392 |
Abstract
The available data on the use of oral contraceptive agents in patients with sickle cell diseases is reviewed. The attitude which considers sickle cell anemia to be a contra-indication to OC's cannot be supported on the basis of available evidence. On the contrary, there are a number of reports where favorable effects of steroids on 'sickling' have been described. It is concluded that modern low-dose combined OC's are the method of choice for contraception in all patients carrying the HbS gene.Entities:
Keywords: Biology; Cardiovascular Effects; Contraception; Contraceptive Methods--indications; Contraceptive Methods--side effects; Diseases; Family Planning; Hematological Effects; Hemic System; Hemoglobin Level; Hereditary Diseases; Oral Contraceptives, Combined; Oral Contraceptives--indications; Oral Contraceptives--side effects; Physiology; Reproductive Control Agents
Mesh：
Substances：
Year: 1983 PMID： 6624392 DOI： 10.3109/00016348309155794
Source DB: PubMed Journal: Acta Obstet Gynecol Scand ISSN： 0001-6349 Impact factor: 3.636